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Abstract Exposure of RINm5F cells to interleukin-1L and to
several chemical NO donors such as sodium nitroprusside (SNP),
SIN-1 and SNAP induce apoptotic events such as the release of
cytochrome c from mitochondria, caspase 3 activation, Bcl-2
downregulation and DNA fragmentation. SNP exposure led to
transient activation of soluble guanylate cyclase (sGC) and
prolonged protein kinase G (PKG) activation but apoptotic
events were not attenuated by inhibition of the sGC/PKG
pathway. Prolonged activation of the cGMP pathway by
exposing cells to the dibutyryl analogue of cGMP for 12 h
induced both apoptosis and necrosis, a response that was
abolished by the PKG inhibitor KT5823. These results suggest
that NO-induced apoptosis in the pancreatic L-cell line is
independent of acute activation of the cGMP pathway.
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1. Introduction
Cytokines and free radicals produced by immune/in£amma-
tory cells have been implicated as e¡ector molecules of L-cell
dysfunction and destruction in insulin-dependent diabetes
mellitus (IDDM) [1^5]. Indeed, combinations of interleukin
(IL)-1L, tumor necrosis factor-K and interferon-Q suppress is-
let function, damage DNA and decrease cell viability in rat
and human pancreatic L-cells [6^10]. There is also evidence
that apoptosis participates in the process of cytokine-induced
L-cell death [11,12]. Most cytokine actions on L-cell damage
involve the generation of nitric oxide (NO) (reviewed in [5]).
NO inhibits mitochondrial respiration and induces Ca2 e¥ux
[13]. In addition NO modulates the mitochondrial permeabil-
ity transition (PT), a process that is linked to release of apop-
togenic factors such as cytochrome c [14]. It has recently been
reported that the apoptotic actions of NO in insulin produc-
ing HIT-T15 cells are mediated by the sGC/PKG system [15].
In the present work, we have studied the role of mitochondria
in NO-mediated apoptosis in rat insulinoma derived RINm5F
cells and its regulation by the cGMP pathway.
2. Materials and methods
2.1. Materials
Cyclosporin A (CsA) was generously provided by Dr. S.F. Borel
(Sandoz), IL-1L was from Genzyme, DEVD.AFC, Z.VAD.FMK,
Z.YVAD.FMK, KT5823, protein kinase A inhibitor 6^22 amide
and protein kinase G substrate-BPDEtide were from Calbiochem,
cGMP (125I) radioimmunoassay (RIA) system, PVDF membranes
and [Q-32P]ATP were from Amersham, cytochrome c antibody
(7H8.2C12) was from Pharmingen, sodium nitroprusside (SNP) was
from Merck, RPMI 1640 was from Biowhittaker, streptomycin, pen-
icillin, glutamine, amphotericin B, cell death detection ELISAplus and
4-(2-aminoethyl)-benzenesulfonyl £uoride hydrochloride (Pefabloc)
were from Boehringer Mannheim, Bcl-2 antibody (DC21) was from
Santa Cruz Biotechnology, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-
one (ODQ) was from Tocris Cookson, S-nitroso-N-acetylpenicill-
amine (SNAP) was from ICN, phosphocellulose paper (P-81) was
from Whatman, N6monomethyl-L-arginine (NMMA), Q-mouse and
Q-rabbit peroxidase conjugate, trypsin, 3-morpholinosydnonimine
(SIN-1) and other chemicals were from Sigma.
2.2. Cell culture
RINm5F cells were maintained in RPMI 1640 supplemented with
100 Wg/ml streptomycin, 100 U/ml penicillin G, 2.5 Wg/ml amphoter-
icin B, 2 mM glutamine, 10% fetal bovine serum in a humidi¢ed
atmosphere of 5% CO2 at 37‡C.
2.3. Measurement of soluble guanylate cyclase (sGC) activity and
cGMP-dependent protein kinase (PKG) activity
RINm5F cells (5U106) were homogenized in 50 Wl of 20 mM
HEPES pH 7.5, 10 mM EGTA, 40 mM glycerophosphate, 1% NP-
40, 25 mM MgCl2, 2 mM sodium orthovanadate, 140 mM NaCl,
1 mM DTT, and a mixture of protease inhibitors containing 1 mM
Pefabloc, 10 Wg/ml aprotinin and 10 Wg/ml leupeptin. Extracts were
centrifuged for 15 min at 15 000Ug and supernatants were used for
enzyme measurements. sGC activity was measured as described in
[16]. Brie£y, aliquots of supernatants corresponding to 30 Wg protein
were incubated for 10 min at 37‡C in a reaction mixture containing
50 mM Tris-HCl pH 7.5, 4 mM MgCl2, 0.5 mM 1-methyl-3-isobutyl-
xanthine, 7.5 mM phosphocreatine, 0.2 mg/ml creatine phosphoki-
nase, and 1 mM GTP with or without 1 mM sodium nitroprusside.
The reaction was terminated by addition of 0.05 N HCl (1:9) and
boiling for 3 min. cGMP levels were measured by a commercial RIA
according to the manufacturer’s instructions. PKG activity was meas-
ured as in [17]. Aliquots of 10 Wl of homogenate (containing 15 Wg
protein) were added to 50 Wl of assay mixture containing 20 mM Tris-
HCl pH 7.4, 200 WM ATP, 100 WM of protein kinase G substrate-
BPDEtide, 20 mM MgCl2, 100 WM 1-methyl-3-isobutylxanthine, 1 WM
protein kinase A inhibitor 6^22 amide and 0.5 WCi [Q-32P]ATP. The
reaction was allowed to proceed at 30‡C for 10 min. To terminate the
reaction, 108 Wl of 10% trichloroacetic acid was added and the mix-
ture was then centrifuged for 2 min a 15 000Ug to precipitate pro-
teins, and supernatants were spotted onto phosphocellulose ¢lters.
After drying for 30 min, the ¢lters were dropped into 75 mM phos-
phoric acid, washed with four changes of phosphoric acid to remove
unreacted [Q-32P]ATP, and once with ethanol. Filters were then dried
and counted in a liquid scintillation counter to measure incorporation
of 32P into peptide.
2.4. Detection of histone-associated DNA
Cells were scraped o¡ the plates and centrifuged at 700Ug for
10 min, washed with PBS and resuspended in lysis bu¡er. DNA frag-
mentation into nucleosomes was determined with the cell death de-
tection ELISAplus according to the manufacturer’s instructions.
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2.5. Assay of cell toxicity
Cells were carefully collected from culture and centrifuged at 3000
rpm for 3 min. Supernatants were collected for analysis of lactate
dehydrogenase (LDH) activity and pellets were lysed in 5 mM Tris
(pH 7.0), 20 mM EDTA, 0.5% Triton X-100. LDH activity was as-
sayed spectrophotometrically following the decrease in absorbance of
NADH at 340 nm. The percentage of LDH released from cells to
culture medium was calculated according to the following formula:
% LDH released  LDH in culture medium
LDH in culture medium LDH in cell lysatesU100
2.6. Measurement of caspase activity
Cells were sedimented at 700Ug for 3 min, washed twice in PBS,
and resuspended in 25 mM HEPES (pH 7.5), 5 mM MgCl2, 1 mM
EGTA supplemented with a cocktail of protease inhibitors containing
1 mM Pefabloc, 10 Wg/ml pepstatin A, and 10 Wg/ml leupeptin. After
30 min incubation on ice, cells were lysed with 40 strokes in a homog-
enizer. Following removal of particulate matter by centrifugation at
15 000Ug for 15 min, supernatants were supplemented with 0.5 mM
EDTA and 2 mM DTT. 50 Wg of cytosolic protein was added to 225 Wl
of assay bu¡er containing 25 mM HEPES (pH 7.5), 0.1% (w/v)
CHAPS, 10 mM DTT, 100 U/ml aprotinin, 1 mM Pefabloc and
100 WM of the caspase substrate DEVD.AFC and incubated for 2 h
at 37‡C. The reaction was terminated by addition of 1.225 ml of ice-
cold assay bu¡er. Fluorescence was measured using an excitation
wavelength of 400 nm and an emission wavelength of 505 nm. Stand-
ards containing 0^1500 pmol of AFC were utilized to determine the
amount of £uorochrome released.
2.7. Western blot analysis of cytochrome c and Bcl-2
Cells were collected by centrifugation at 700Ug for 3 min at 4‡C,
washed twice with ice-cold PBS and centrifuged at 700Ug for 3 min.
For analysis of cytochrome c, cell pellets were resuspended in 60 Wl of
extraction bu¡er containing 220 mM mannitol, 68 mM sucrose,
50 mM HEPES pH 7.5, 50 mM KCl, 5 mM EGTA, 2 mM MgCl2,
1 mM DTT, 1 mM Pefabloc, 10 Wg/ml pepstatin A and 10 Wg/ml
leupeptin. After incubation on ice for 30 min, cells were spun at
15 000Ug for 15 min. Aliquots of 10 Wg protein were resolved on
12.5% SDS-polyacrylamide gel and then blotted to PVDF mem-
branes. Membranes were incubated for 6 h at room temperature
with anti-cytochrome c monoclonal antibody 7H8.2C12 (diluted
1:2000). Following removal of the excess of primary antibody by
three washes with 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1%
Tween-20, membranes were incubated with anti-mouse IgG conju-
gated with peroxidase (1:20 000) for 1 h. Bound antibodies were de-
tected by enhanced chemiluminescence. For analysis of Bcl-2, cells
were placed in 50 Wl of bu¡er (20 mM Tris-HCl, 137 mM NaCl,
5 mM MgCl2, 10% glycerol and 1% NP-40, 1 mM Pefabloc, 10 Wg/
ml pepstatin A and 10 Wg/ml leupeptin). Lysis was carried out at 4‡C
for 30 min. Cell lysates were sonicated for 10 s on ice. Lysates were
then centrifuged at 15 000Ug for 15 min. 10 Wg of cytosolic protein
was resolved by SDS-PAGE electrophoresis as above and Bcl-2 was
detected by immunoblotting and enhanced chemiluminescence.
3. Results
3.1. E¡ect of sodium nitroprusside on the GC/PKG system
Fig. 1 shows that RINm5F cells contain soluble guanylate
cyclase activity that was stimulated by sodium nitroprusside.
The magnitude of stimulation is dependent on previous expo-
sure of cells to the NO donor. Thus, short periods of exposure
of cells (0.5^1.0 h) to SNP slightly increased NO-activated
enzyme activity; longer exposures (2.0^4.0 h) led to a substan-
tial reduction in NO-activated enzyme activity. Basal enzyme
activity was not signi¢cantly a¡ected by exposure of cells to
the NO donor. Table 1 shows that PKG is activated 10-fold
after 0.5 h of exposure to 1 mM SNP. This activation remains
stable after 12 h of exposure. The addition of cGMP to the
assay system increased 10-fold PKG activity in extracts from
control non-exposed cells, but failed to further enhance PKG
activity in SNP-treated cells. The guanylate cyclase inhibitor
ODQ fully blocked PKG activation induced by short (0.5 h)
exposure to SNP, but failed to do this at longer periods of
treatment (6.0^12.0 h).
3.2. Nitric oxide and cytochrome c release
Fig. 2 shows that the chemical NO donor SNP induces a
time-dependent release of cytochrome c in RINm5F cells. This
action was mimicked by other NO donors such as SNAP and
SIN and by exposure of cells to IL-1L. The e¡ect of IL-1L was
fully reversed by the presence of the NO synthase inhibitor
NMMA.
CsA, a speci¢c inhibitor of the permeability transition pore
(PT) opening in mitochondria, partially reversed the e¡ect of
SNP and IL-1L on cytochrome c release (Fig. 3).
3.3. Regulation of NO-dependent cytochrome c release
Fig. 4A shows that neither the inhibitor of guanylate cy-
clase ODQ nor the inhibitor of PKG KT5823 is able to coun-
teract the actions of chemically generated NO on cytochrome
c release from mitochondria. On the other hand, exposure of
cells to the dibutyryl analogue of cGMP (dbcGMP) led to
release of cytochrome c from mitochondria to cytosol. This
Fig. 1. E¡ect of SNP exposure on soluble GC activity in RINm5F
cells. Homogenates from control untreated cells and from cells ex-
posed to 1 mM SNP for 0.5, 1, 2, or 4 h were assayed for basal
and SNP-activated enzyme activity as described in Section 2. Data
are means þ S.D. from three independent experiments
Table 1
Time course of NO-induced PKG activity in extracts from RINm5F
cells
Time (h) PKG activity (nmol/min/mg protein)
1 mM SNP 1 mM SNP+10 WM ODQ
No addition 10 WM cGMP
0 1.2 þ 0.19 11.6 þ 0.59a 1.2 þ 0.17
0.5 12.4 þ 0.42a 11.9 þ 1.15a 1.6 þ 0.83
6.0 9.2 þ 1.06a;b 9.7 þ 0.23a;b 9.5 þ 0.25a;b
12.0 10.5 þ 1.21a;b 10.4 þ 0.48a;b 9.4 þ 0.85a;b
Cells were exposed to either 1 mM SNP or 1 mM SNP and 10 WM
ODQ for the indicated times and basal and cGMP-stimulated pro-
tein kinase G enzyme activity was measured as described in Section
2. When appropriate, ODQ was added 30 min before SNP. Data
are means þ S.D. from three independent experiments. One-way AN-
OVA was used for multiple group comparisons.
aSigni¢cantly greater than 0 h (P6 0.05).
bSigni¢cantly greater than 0.5 h (P6 0.05).
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action was fully prevented by KT5823. Similar results were
obtained when NO was endogenously generated following ex-
posure of cells to IL-1L (Fig. 4B). In addition, both SNP- and
IL-1L-induced cytochrome c release were partially prevented
by the caspase inhibitor Z.VAD.FMK (Fig. 4C). The relation-
ship between caspases and cytochrome c release from mito-
chondria is shown in Fig. 5A. Exposure of cells to 1 mM SNP
led to caspase 3 activation in a time-dependent manner and
inhibition of mitochondrial PT with CsA partially prevented
this e¡ect. Fig. 5B shows that endogenous generation of NO
following exposure of cells to IL-1L led to a 10-fold increase
in caspase 3 activity that was not dependent on the cGMP
system.
3.4. NO and DNA damage and cell necrosis
Fig. 6 shows that both SNP- and IL-1L-induced DNA frag-
mentation were not inhibited by either ODQ or KT5823. By
contrast, dbcGMP-induced DNA fragmentation was fully
prevented by KT5823. SNP, IL-1L and dbcGMP stimulated
the release of LDH to medium. Inhibition of the sGC/cGMP
pathway with ODQ and KT5823 blocked this action.
3.5. NO and Bcl-2 degradation
The e¡ect of SNP and dbcGMP on Bcl-2 levels is shown in
Fig. 7. SNP exposure led to a time-dependent downregulation
of the protein. The action of SNP was fully prevented by
addition of the caspase inhibitor Z.VAD.FMK. By contrast,
the protein kinase G inhibitor KT5823 failed to block the
e¡ect of SNP. Exposure of cells to dbcGMP for 12 h led to
a decrease in Bcl-2 protein levels that was fully counteracted
by KT5823.
4. Discussion
Evidence has been accumulated over the past years con-
cerning the role of apoptosis in the control of L-cell popula-
tion and in the pathogenesis of IDDM [11,12,18^21]. Apop-
totic rodent L-cell death seems to be mediated by the
generation of NO in a process regulated by in£ammatory
cytokines [10,18^22]. The results of this study indicate that
NO activates caspase 3 in rat insulinoma-derived RINm5F
Fig. 2. NO-induced release of cytochrome c from mitochondria. A:
Release of cytochrome c induced by exogenous NO and by IL-1L.
Cells were exposed to SNAP and SIN-1 for 15 h and to IL-1L and
to IL-1L+NMMA for 24 h. B: Time course of SNP-induced release
of cytochrome c. Cytosolic extracts were prepared at the indicated
times following exposure to SNP. Immunoblots are representative of
three independent experiments.
Fig. 3. Inhibition of SNP- and IL-1L-induced cytochrome c release
by CsA. When appropriate, CsA was added 1 h before addition of
SNP and IL-1L and cells were cultured for 12 h (A) and 18 h (B).
Immunoblots are representative of three independent experiments.
Fig. 4. Role of cGMP and caspases on NO-induced release of cyto-
chrome c. A: SNP- and cGMP-induced release of cytochrome c.
ODQ and KT5823 were added 30 min before addition of SNP and
dbcGMP. Cells were then cultured for 12 h. B: IL-1L-induced re-
lease of cytochrome c. ODQ was added 30 min before addition of
IL-1L. Cells were then cultured for 24 h. C: E¡ect of Z.VAD.FMK
on NO-induced cytochrome c release from mitochondria.
Z.VAD.FMK was added 30 min before the addition of 1 mM SNP
and IL-1L. Cells were then cultured for 12 and 18 h respectively.
Immunoblots are representative of three independent experiments.
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cells and that this event is preceded by release of cytochrome c
from mitochondria in a cGMP-independent manner. The
study also shows that NO-induced DNA fragmentation is
cGMP-independent.
The actions of NO on apoptosis depend on cell type, con-
centration, interaction with other radicals, and the redox state
of cells [23^30]. In cell systems where NO is anti-apoptotic,
the cGMP pathway is involved [31^35]. Pancreatic L-cell
apoptosis is controlled by cGMP in a di¡erent manner. It
has been reported that cGMP is involved in NO-induced
apoptosis [15]. In fact, our data indicate that RINm5F cells
are endowed with a GC/PKG system and that exposure of
cells to the NO donor SNP leads to initial activation of GC
followed by a decay with longer periods of treatment. These
results are in agreement with those reported in smooth muscle
cells, where a decrease in GC mRNA stability induced by NO
has been described [36,37]. On the other hand, NO exposure
led to a sustained increase in PKG activity that was resistant
to blockade of GC with ODQ. It is entirely possible that
chronic exposure to NO leads to PKG activation by cGMP-
independent mechanisms such as phosphorylation [38,39]. Our
results also indicate that NO exposure leads to necrotic cell
death and apoptosis and that these actions were mimicked
by dbcGMP. PKG inhibitors counteracted the actions of
Fig. 5. E¡ect of PT and cGMP pathway inhibitors on NO-depend-
ent caspase 3 activation. A: E¡ect of CsA on NO-induced caspase
3 activation. When appropriate, CsA was added 1 h before time 0.
B: E¡ect of cGMP pathway inhibitors on IL-1L-induced caspase 3
activation. Cells were exposed to IL-1L for 24 h in the presence of
ODQ and KT5823 respectively. Data are means þ S.D. from 3^4 in-
dependent experiments.
Fig. 6. NO-induced apoptosis occurs in a cGMP-independent man-
ner. ODQ and KT5823 was added 30 min before addition of SNP,
IL-1L and dbcGMP. Cells were then cultured for 12 h (SNP- and
dbcGMP-treated cells) and for 24 h (IL-1L-treated cells). A: DNA
fragmentation into nucleosomes. B: Percentage of LDH release to
medium. Data are means þ S.D. from 3^4 independent experiments.
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dbcGMP on apoptotic cell death and necrosis, but they failed
to block the actions of NO on apoptosis. These ¢ndings speak
in favor of the notion that NO triggers apoptosis in RINm5F
cells in a cGMP-independent manner. We also found that
NO-induced LDH release is cGMP-dependent. This is in
agreement with cell viability studies performed in HIT-T15
cells and suggests that cGMP might control processes that
lead to necrosis in pancreatic cells [15].
Cytochrome c release from mitochondria has been involved
in the control of caspase activation during apoptosis [40^46].
NO generated both by chemical donors and by exposure of
cells to IL-1L provoked the release of cytochrome c from
mitochondria in RINm5F cells. In fact, this organelle seems
to play an important role in controlling NO-induced apopto-
sis in RINm5f cells since NO-induced caspase 3-like activation
and DNA fragmentation were preceded by the appearance of
cytochrome c in cytosol. It is now known that the activation
of e¡ector caspases and nuclear apoptosis is controlled by
apoptogenic factors such as cytochrome c released from mi-
tochondria following opening of PT pores [14,46^50]. The
¢nding that the inhibitor of the PT pore CsA partially coun-
teracted NO-induced apoptotic events in these cells supports
the notion that NO triggers mitochondrial PT [51].
The possibility that NO-induced mitochondrial PT was sec-
ondary to Bcl-2 degradation was tested with the protease in-
hibitor Z.VAD.FMK. Whereas Z.VAD.FMK fails to fully
counteract the release of cytochrome c, it prevents Bcl-2
downregulation. This suggest that Z.VAD.FMK-inhibited
proteases participate in the exacerbation of the actions of
NO at the mitochondrial level.
It has been shown that low concentrations of NO increase
the expression of Bcl-2 protein in a cGMP-dependent manner
and prevent apoptosis in some cell systems [51]. Although
a similar action in RINm5F cells cannot be ruled out, our
results indicated that the apoptotic action of NO at high
concentrations depends on Bcl-2 downregulation and is
secondary to caspase activation. Besides, the ¢nding that
inhibition of PKG with KT5823 counteracted cGMP-induced
Bcl-2 downregulation but failed to block NO-induced Bcl-2
downregulation indicates that the cGMP/PKG system is not
involved in the action of NO on Bcl-2 levels. According to its
pleiotropic nature, NO can trigger alternative apoptotic path-
ways such as the upregulation of p53 and CD95/Fas receptor
proteins [24,26,34,52,53].
Our data suggest that mitochondrial handling of key apop-
totic events in insulin producing cells is a¡ected by NO in a
cGMP-independent manner. Future studies will be required to
elucidate the signaling pathways that mediate the action of
NO in mitochondria.
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